|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Garrido-Laguna I and Hidalgo M: Pancreatic
cancer: From state-of-the-art treatments to promising novel
therapies. Nat Rev Clin Oncol. 12:319–334. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hartwig W, Werner J, Jäger D, Debus J and
Büchler MW: Improvement of surgical results for pancreatic cancer.
Lancet Oncol. 14:e476–e485. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lu XJ, Shi Y, Chen JL and Ma S:
Krüppel-like factors in hepatocellular carcinoma. Tumour Biol.
36:533–541. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lahiri SK and Zhao J: Krüppel-like factor
8 emerges as an important regulator of cancer. Am J Transl Res.
4:357–363. 2012.PubMed/NCBI
|
|
6
|
Wang X, Zheng M, Liu G, Xia W,
McKeown-Longo PJ, Hung MC and Zhao J: Krüppel-like factor 8 induces
epithelial to mesenchymal transition and epithelial cell invasion.
Cancer Res. 67:7184–7193. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hu JH, Navas P, Cao H, Stamatoyannopoulos
G and Song CZ: Systematic RNAi studies on the role of Sp/KLF
factors in globin gene expression and erythroid differentiation. J
Mol Biol. 366:1064–1073. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wei H, Wang X, Gan B, Urvalek AM,
Melkoumian ZK, Guan JL and Zhao J: Sumoylation delimits KLF8
transcriptional activity associated with the cell cycle regulation.
J Biol Chem. 281:16664–16671. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang P, Basu P, Redmond LC, Morris PE,
Rupon JW, Ginder GD and Lloyd JA: A functional screen for
Krüppel-like factors that regulate the human gamma-globin gene
through the CACCC promoter element. Blood Cells Mol Dis.
35:227–235. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
van Vliet J, Turner J and Crossley M:
Human Krüppel-like factor 8: A CACCC-box binding protein that
associates with CtBP and represses transcription. Nucleic Acids
Res. 28:1955–1962. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lloyd JA: KLF8 sets the pace for the cell
cycle through interactions with p300 and PCAF. Cell Cycle.
9:650–651. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Urvalek AM, Wang X, Lu H and Zhao J: KLF8
recruits the p300 and PCAF co-activators to its amino terminal
activation domain to activate transcription. Cell Cycle. 9:601–611.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mehta TS, Lu H, Wang X, Urvalek AM, Nguyen
KH, Monzur F, Hammond JD, Ma JQ and Zhao J: A unique sequence in
the N-terminal regulatory region controls the nuclear localization
of KLF8 by cooperating with the C-terminal zinc-fingers. Cell Res.
19:1098–1109. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhao J, Bian ZC, Yee K, Chen BP, Chien S
and Guan JL: Identification of transcription factor KLF8 as a
downstream target of focal adhesion kinase in its regulation of
cyclin D1 and cell cycle progression. Mol Cell. 11:1503–1515. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yang T, Cai SY, Zhang J, Lu JH, Lin C,
Zhai J, Wu MC and Shen F: Krüppel-like factor 8 is a new
Wnt/beta-catenin signaling target gene and regulator in
hepatocellular carcinoma. PLoS One. 7:e396682012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Han S, Han L, Sun H, Zan X, Zhou Z, Xu K,
Yao Y and Liu Q: Krüppel-like factor expression and correlation
with FAK, MMP9 and E-cadherin expression in hepatocellular
carcinoma. Mol Med Rep. 8:81–88. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li JC, Yang XR, Sun HX, Xu Y, Zhou J, Qiu
SJ, Ke AW, Cui YH, Wang ZJ, Wang WM, et al: Up-regulation of
Krüppel-like factor 8 promotes tumor invasion and indicates poor
prognosis for hepatocellular carcinoma. Gastroenterology.
1392146–2157. (e12)2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen G, Yang W, Jin W, Wang Y, Tao C and
Yu Z: Lentivirus-mediated gene silencing of KLF8 reduced the
proliferation and invasion of gastric cancer cells. Mol Biol Rep.
39:9809–9815. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu L, Liu N, Xu M, Liu Y, Min J, Pang H,
Zhang N and Zhang H and Zhang H: Lentivirus-delivered Krüppel-like
factor 8 small interfering RNA inhibits gastric cancer cell growth
in vitro and in vivo. Tumour Biol. 33:53–61. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hsu LS, Wu PR, Yeh KT, Yeh CM, Shen KH,
Chen CJ and Soon MS: Positive nuclear expression of KLF8 might be
correlated with shorter survival in gastric adenocarcinoma. Ann
Diagn Pathol. 18:74–77. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang WF, Li J, Du LT, Wang LL, Yang YM,
Liu YM, Liu H, Zhang X, Dong ZG, Zheng GX and Wang CX: Krüppel-like
factor 8 overexpression is correlated with angiogenesis and poor
prognosis in gastric cancer. World J Gastroenterol. 19:4309–4315.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang X, Lu H, Urvalek AM, Li T, Yu L,
Lamar J, DiPersio CM, Feustel PJ and Zhao J: KLF8 promotes human
breast cancer cell invasion and metastasis by transcriptional
activation of MMP9. Oncogene. 30:1901–1911. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu N, Wang Y, Zhou Y, Pang H, Zhou J,
Qian P, Liu L and Zhang H: Krüppel-like factor 8 involved in
hypoxia promotes the invasion and metastasis of gastric cancer via
epithelial to mesenchymal transition. Oncol Rep. 32:2397–2404.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang H, Liu L, Wang Y, Zhao G, Xie R, Liu
C, Xiao X, Wu K, Nie Y, Zhang H and Fan D: KLF8 involves in
TGF-beta-induced EMT and promotes invasion and migration in gastric
cancer cells. J Cancer Res Clin Oncol. 139:1033–1042. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fu WJ, Li JC, Wu XY, Yang ZB, Mo ZN, Huang
JW, Xia GW, Ding Q, Liu KD and Zhu HG: Small interference RNA
targeting Krüppel-like factor 8 inhibits the renal carcinoma 786-0
cells growth in vitro and in vivo. J Cancer Res Clin Oncol.
136:1255–1265. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Schnell O, Romagna A, Jaehnert I, Albrecht
V, Eigenbrod S, Juerchott K, Kretzschmar H, Tonn JC and Schichor C:
Krüppel-like factor 8 (KLF8) is expressed in gliomas of different
WHO grades and is essential for tumor cell proliferation. PLoS One.
7:e304292012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yan Q, Zhang W, Wu Y, Wu M, Zhang M, Shi
X, Zhao J, Nan Q, Chen Y, Wang L, et al: KLF8 promotes
tumorigenesis, invasion and metastasis of colorectal cancer cells
by transcriptional activation of FHL2. Oncotarget. 6:25402–25417.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lu H, Hu L, Yu L, Wang X, Urvalek AM, Li
T, Shen C, Mukherjee D, Lahiri SK, Wason MS and Zhao J: KLF8 and
FAK cooperatively enrich the active MMP14 on the cell surface
required for the metastatic progression of breast cancer. Oncogene.
33:2909–2917. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li T, Lu H, Mukherjee D, Lahiri SK, Shen
C, Yu L and Zhao J: Identification of epidermal growth factor
receptor and its inhibitory microRNA141 as novel targets of
Krüppel-like factor 8 in breast cancer. Oncotarget. 6:21428–21442.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cao CY, Mok SW, Cheng VW and Tsui SK: The
FHL2 regulation in the transcriptional circuitry of human cancers.
Gene. 572:1–7. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kleiber K, Strebhardt K and Martin BT: The
biological relevance of FHL2 in tumour cells and its role as a
putative cancer target. Anticancer Res. 27:55–61. 2007.PubMed/NCBI
|
|
32
|
Zienert E, Eke I, Aust D and Cordes N:
LIM-only protein FHL2 critically determines survival and
radioresistance of pancreatic cancer cells. Cancer Lett. 364:17–24.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Al-Nomani L, Friedrichs J, Schüle R,
Buttner R and Friedrichs N: Tumoral expression of nuclear cofactor
FHL2 is associated with lymphatic metastasis in sporadic but not in
HNPCC-associated colorectal cancer. Pathol Res Pract. 211:171–174.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gullotti L, Czerwitzki J, Kirfel J,
Propping P, Rahner N, Steinke V, Kahl P, Engel C, Schüle R,
Buettner R and Friedrichs N: FHL2 expression in peritumoural
fibroblasts correlates with lymphatic metastasis in sporadic but
not in HNPCC-associated colon cancer. Lab Invest. 91:1695–1705.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Qiao L, Wang Y, Pang R, Wang J, Dai Y, Ma
J, Gu Q, Li Z, Zhang Y, Zou B, et al: Oncogene functions of FHL2
are independent from NF-kappaBIalpha in gastrointestinal cancer.
Pathol Oncol Res. 15:31–36. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gabriel B, Fischer DC, Orlowska-Volk M,
zur Hausen A, Schüle R, Müller JM and Hasenburg A: Expression of
the transcriptional coregulator FHL2 in human breast cancer: A
clinicopathologic study. J Soc Gynecol Investig. 13:69–75. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ding L, Wang Z, Yan J, Yang X, Liu A, Qiu
W, Zhu J, Han J, Zhang H, Lin J, et al: Human four- and -a-half LIM
family members suppress tumor cell growth through a TGF-beta-like
signaling pathway. J Clin Invest. 119:349–361. 2009.PubMed/NCBI
|
|
38
|
Zhang W, Wang J, Zou B, Sardet C, Li J,
Lam CS, Ng L, Pang R, Hung IF, Tan VP, et al: Four and a half LIM
protein 2 (FHL2) negatively regulates the transcription of
E-cadherin through interaction with Snail1. Eur J Cancer.
47:121–130. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
McGrath MJ, Binge LC, Sriratana A, Wang H,
Robinson PA, Pook D, Fedele CG, Brown S, Dyson JM, Cottle DL, et
al: Regulation of the transcriptional coactivator FHL2 licenses
activation of the androgen receptor in castrate-resistant prostate
cancer. Cancer Res. 73:5066–5079. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
He HJ, Gu XF, Xu WH, Yang DJ, Wang XM and
Su Y: Krüppel-like factor 8 is a novel androgen receptor
co-activator in human prostate cancer. Acta Pharmacol Sin.
34:282–288. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Li T, Lu H, Shen C, Lahiri SK, Wason MS,
Mukherjee D, Yu L and Zhao J: Identification of epithelial stromal
interaction 1 as a novel effector downstream of Kruppel-like factor
8 in breast cancer invasion and metastasis. Oncogene. 33:4746–4755.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Gabriel B, Mildenberger S, Weisser CW,
Metzger E, Gitsch G, Schüle R and Müller JM: Focal adhesion kinase
interacts with the transcriptional coactivator FHL2 and both are
overexpressed in epithelial ovarian cancer. Anticancer Res.
24:921–927. 2004.PubMed/NCBI
|
|
43
|
Wang X, Urvalek AM, Liu J and Zhao J:
Activation of KLF8 transcription by focal adhesion kinase in human
ovarian epithelial and cancer cells. J Biol Chem. 283:13934–13942.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Yi XP, Han T, Li YX, Long XY and Li WZ:
Simultaneous silencing of XIAP and survivin causes partial
mesenchymal-epithelial transition of human pancreatic cancer cells
via the PTEN/PI3K/Akt pathway. Mol Med Rep. 12:601–608. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Han T, Yi XP, Liu B, Ke MJ and Li YX:
MicroRNA-145 suppresses cell proliferation, invasion and migration
in pancreatic cancer cells by targeting NEDD9. Mol Med Rep.
11:4115–4120. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Deer EL, González-Hernández J, Coursen JD,
Shea JE, Ngatia J, Scaife CL, Firpo MA and Mulvihill SJ: Phenotype
and genotype of pancreatic cancer cell lines. Pancreas. 39:425–435.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Beuran M, Negoi I, Paun S, Ion AD, Bleotu
C, Negoi RI and Hostiuc S: The epithelial to mesenchymal transition
in pancreatic cancer: A systematic review. Pancreatology.
15:217–225. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Jiang JH, Liu C, Cheng H, Lu Y, Qin Y, Xu
YF, Xu J, Long J, Liu L, Ni QX and Yu XJ: Epithelial-mesenchymal
transition in pancreatic cancer: Is it a clinically significant
factor. Biochim Biophys Acta. 1855:43–49. 2015.PubMed/NCBI
|
|
50
|
Yi X, Li Y, Zai H, Long X and Li W: KLF8
knockdown triggered growth inhibition and induced cell phase arrest
in human pancreatic cancer cells. Gene. 585:22–27. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
